Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Loula Papageorgiou
Prognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent Regimens
Oncologist
Cancer Research
Medicine
Oncology
Related publications
The Ratio of the Absolute Lymphocyte Count to the Absolute Monocyte Count Is Associated With Prognosis in Hodgkin's Lymphoma: Correlation With Tumor-Associated Macrophages
Oncologist
Cancer Research
Medicine
Oncology
HIV Status Does Not Influence Outcome in Patients With Classical Hodgkin Lymphoma Treated With Chemotherapy Using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the Highly Active Antiretroviral Therapy Era
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Long-Term Follow Up of Patients With Human Immunodeficiency Virus Infection and Advanced Stage Hodgkin's Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine and Dacarbazine
Haematologica
Hematology
Prognostic Significance of Peripheral Blood Absolute Lymphocyte Count and Derived Neutrophil to Lymphocyte Ratio in Patients With Newly Diagnosed Extranodal Natural Killer/T-Cell Lymphoma
Cancer Management and Research
Oncology
A Pilot Trial of Adriamycin, Pembrolizumab, Vinblastine and Dacarbazine (Apvd) for Patients With Untreated Classical Hodgkin Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
The Prognostic Impact of Neutrophil-To-Lymphocyte Ratio, Lymphocyte-To-Monocyte Ratio, and Platelet-To-Lymphocyte Ratio in Patients With Advanced Colorectal Cancer Treated With First-Line Chemotherapy
Przeglad Gastroenterologiczny
Gastroenterology
Pre-Treatment Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio Are Prognostic of Progression in Early Stage Classical Hodgkin Lymphoma
British Journal of Haematology
Hematology
Nivolumab Plus Doxorubicin, Vinblastine and Dacarbazine for Newly Diagnosed Advanced-Stage Classical Hodgkin Lymphoma: Checkmate 205 Cohort D 2-Year Follow-Up
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Prognostic Value of Lymphocyte/Monocyte Ratio and Neutrophil/Lymphocyte Ratio at Diagnosis of Follicular Lymphoma.
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
